动脉导管未闭

Clyman RI, Mauray F, Roman C, et al. Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2. J Pediatr. 1983;102:907-911.

• 摘要

Gersony WM, Peckham GJ, Ellison RC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983 Jun;102(6):895-906.

• 摘要

Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117:1113-1121.

• 摘要

Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol. 2001;6:63-73.

• 摘要

Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F464-6.

• 全文
• 摘要

Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2007;(1):CD003480.

• 全文
• 摘要

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. J Am Dent Assoc. 2007 Jun;138(6):739-45, 747-60.

• 摘要

1.  Kitterman JA, Edmunds LH Jr, Gregory GA, et al. Patent ductus arteriosus in premature infants, incidence, relation to pulmonary disease and management. N Engl J Med. 1972;287:473-477.

• 摘要

2.  Moore P, Brook MM, Heymann MA. Patent ductus arteriosus. In: Moss and Adams heart disease in infants, children and adolescents. Philadelphia, PA: Lippincott, Williams and Wilkins; 2001.

3.  Gittenburger-De Groot AC, van Ertbruggen I, Moulaert AJ, et al. The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr. 1980;96:88-93.

• 摘要

4.  Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics. 2001;107:E32.

• 全文
• 摘要

5.  Lloyd TR, Beekman RH III. Clinical silent patent ductus arteriosus. Am Heart J. 1994;127:1664-1665.

6.  Rothman KJ, Fyler DC. Sex, birth order, and maternal age characteristics of infants with congenital heart defects. Am J Epidemiol. 1976;104:527-534.

• 摘要

7.  Miao CY, Zuberbuhler JS, Zuberbuhler JR. Prevalence of congenital cardiac anomalies at high altitude. J Am Coll Cardiol. 1988;12:224-228.

• 摘要

8.  Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev. 1998;50:35-58.

• 全文
• 摘要

9.  Thebaud B, Michelakis ED, Wu XC, et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation. 2004;110:1372-1379.

• 全文
• 摘要

10.  Michelakis E, Rebeyka I, Bateson J, et al. Voltage-gated potassium channels in human ductus arteriosus. Lancet. 2000;356:134-137.

• 摘要

11.  Olley PM, Coceani F. Lipid mediators in the control of the ductus arteriosus. Am Rev Respir Dis. 1987;136:218-219.

• 摘要

12.  Gittenberger-de Groot AC, Strengers JL, Mentink M, et al. Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol. 1985;6:394-404.

• 摘要

13.  Clyman RI, Chan CY, Mauray F, et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the role of postnatal constriction, hypoxia and gestation. Pediatr Res. 1999;45:19-29.

14.  Clyman RI, Mauray F, Roman C, et al. Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2. J Pediatr. 1983;102:907-911.

• 摘要

15.  Rudolph AM, Mayer FE, Nadas AS, et al. Patent ductus arteriosus. A clinical and hemodynamic study of patients in the first year of life. Pediatrics. 1958;22:892-904.

• 摘要

16.  Baylen BG, Ogata H, Oguchi K, et al. The contractility and performance of the pre-term left ventricle before and after early patent ductus arteriosus occlusion in surfactant-treated lambs. Pediatr Res. 1985;19:1053-1058.

• 摘要

17.  Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000 Jul;137(1):68-72.

• 摘要

18.  Marshall DD, Kotelchuck M, Young TE, et al. Risk factors for chronic lung disease in the surfactant era: A North Carolina population-based study of very low birth weight infants. Pediatrics. 1999 Dec;104(6):1345-50.

• 摘要

19.  Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995 Apr;126(4):605-10.

• 摘要

20.  Osborn DA, Evans N, Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics. 2003 Jul;112(1 Pt 1):33-9.

• 摘要

21.  Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):184-8.

• 摘要

22.  Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr. 1984 Jun;104(6):915-20.

• 摘要

23.  Hoffman JI, Buckberg GD. Regional myocardial ischemia: causes, prediction, and prevention. Vasc Surg. 1974;18:115-130.

• 摘要

24.  Rudolph AM, Drorbaugh JE, Auld PA, et al. Studies on the circulation in the neonatal period. The circulation in the respiratory distress syndrome. Pediatrics. 1961;27:551-566.

• 摘要

25.  Gersony WM, Peckham GJ, Ellison RC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983 Jun;102(6):895-906.

• 摘要

26.  Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117:1113-1121.

• 摘要

27.  Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2010;(1):CD001079.

• 摘要

28.  Gibson S, Lewis KC. Congenital heart disease following maternal rubella during pregnancy. Am J Dis Child. 1952;83:317-319.

• 摘要

29.  Campbell M. Natural history of patent ductus arteriosus. Br Heart J. 1968 Jan;30(1):4-13.

• 摘要

30.  Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006 Oct 24;114(17):1873-82.

• 全文
• 摘要

31.  Clyman RI, Mauray F, Roman C, et al. Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs. J Pediatr. 1980;97:455-461.

• 摘要

32.  Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation. 1968;38:604-617.

• 摘要

33.  Char F. Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set ears a new syndrome? Birth Defects Orig Artic Ser. 1978;14:303-305.

• 摘要

34.  Mani A, Meraji SM, Houshyar R, et al. Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Nat Acad Sci USA. 2002;99:15054-15059.

• 全文
• 摘要

35.  Bevilacqua E, Brunelli R, Anceschi MM. Review and meta-analysis: benefits and risks of multiple courses of antenatal corticosteroids. J Matern Fetal Neonatal Med. 2010;23:244-260.

• 摘要

36.  Gibson GA. Persistence of the arterial duct and its diagnosis. Edinburgh Med J. 1900;8:1-5.

37.  Sahn DJ, Allen HD. Real-time cross-sectional echocardiographic imaging and measurement of the patent ductus arteriosus in infants and children. Circulation. 1978 Aug;58(2):343-54.

• 摘要

38.  Urquhart DS, Nicholl RM. How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate? Arch Dis Child. 2003 Jan;88(1):85-6.

• 全文
• 摘要

39.  Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010 Dec;31(23):2915-57.

• 全文
• 摘要

40.  Hiraishi S, Misawa H, Oguchi K, et al. Two-dimensional Doppler echocardiographic assessment of closure of the ductus arteriosus in normal newborn infants. J Pediatr. 1987;111:755-760.

• 摘要

41.  Stevenson JG, Kawabori I, Guntheroth WG. Pulsed Doppler echocardiographic diagnosis of patent ductus arteriosus: sensitivity, specificity, limitations, and technical features. Cathet Cardiovasc Diagn. 1980;6:255-263.

• 摘要

42.  Zanardo V, Milanesi O, Trevisanuto D, et al. Early screening and treatment of "silent" patent ductus arteriosus in prematures with RDS. J Perinat Med. 1991;19:291-295.

• 摘要

43.  Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol. 2001;6:63-73.

• 摘要

44.  Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F464-6.

• 全文
• 摘要

45.  McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007 Nov;92(6):F424-7.

• 摘要

46.  Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol. 2007 Mar;27(3):164-70.

• 摘要

47.  Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007 Jul;92(4):F244-7.

• 摘要

48.  Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2014;(12):CD000503.

• 全文
• 摘要

49.  Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;(7):CD000174.

• 摘要

50.  Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2007;(1):CD003480.

• 全文
• 摘要

51.  Attridge JT, Kaufman DA, Lim DS, et al. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2009 May;94(3):F178-82.

• 摘要

52.  Aranda JV, Clyman R, Cox B, et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol. 2009 Mar;26(3):235-45.

• 摘要

53.  Jones LJ, Craven PD, Attia J, et al. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F45-52.

• 摘要

54.  Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2015;(2):CD003481.

• 全文
• 摘要

55.  Neumann R, Schulzke SM, Bührer C. Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology. 2012;102(1):9-15.

• 摘要

56.  Mitra S, Florez ID, Tamayo ME, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA. 2018 Mar 27;319(12):1221-1238.

• 全文
• 摘要

57.  Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One. 2013 Nov 4;8(11):e77888.

• 全文
• 摘要

58.  Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr. 2014 Mar;164(3):510-4.e1.

• 摘要

59.  Gross RE, Hubbard JP. Surgical ligation of a patent ductus arteriosus: a report of first successful case. JAMA. 1939;112:729-731.

• 摘要

60.  Koehne PS, Bein G, Alexi-Meskhishvili V, et al. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med. 2001;29(4):327-34.

• 摘要

61.  Little DC, Pratt TC, Blalock SE, et al. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg. 2003 Mar;38(3):492-6.

• 摘要

62.  Lee LC, Tillet A, Tulloh R. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr. 2006 May 11;6:15.

• 全文
• 摘要

63.  Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013;(3):CD003951.

• 全文
• 摘要

64.  Clyman R, Cassady G, Kirklin JK, et al. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Ped. 2009 Jun;154(6):873-6.

• 摘要

65.  Mosalli R, Alfaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev. 2008;(1):CD006181.

• 摘要

66.  Yee WH, Scotland J; Evidence-based Practice for Improving Quality (EPIQ) Evidence Review Group. Does primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks' gestation reduce the incidence of necrotizing enterocolitis? Paediatr Child Health. 2012 Mar;17(3):125-8.

• 全文
• 摘要

67.  Laborde F, Folliguet TA, Etienne PY, et al. Video-thoracoscopic surgical interruption of patent ductus arteriosus. Routine experience in 332 pediatric cases. Eur J Cardiothorac Surg. 1997 Jun;11(6):1052-5.

• 摘要

68.  Butera G, De Rosa G, Chessa M, et al. Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart. 2004 Dec;90(12):1467-70.

• 全文
• 摘要

69.  Masura J, Walsh KP, Thanopoulous B, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol. 1998 Mar 15;31(4):878-82.

• 摘要

70.  Masura J, Tittel P, Gavora P, et al. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J. 2006 Mar;151(3):755.e7-755.e10.

• 摘要

71.  Magee AG, Huggon IC, Seed PT, et al. Transcatheter coil occlusion of the arterial duct; results of the European Registry. Eur Heart J. 2001 Oct;22(19):1817-21.

• 全文
• 摘要

72.  Al-Ata J, Arfi AM, Hussain A, et al. The efficacy and safety of the Amplatzer ductal occluder in young children and infants. Cardiol Young. 2005 Jun;15(3):279-85.

• 摘要

73.  Grifka RG. Transcatheter closure of the patent ductus arteriosus. Catheter Cardiovasc Interv. 2004 Apr;61(4):554-70.

• 摘要

74.  Fischer G, Stieh J, Uebing A, et al. Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder. Heart. 2001 Oct;86(4):444-7.

• 全文
• 摘要

75.  Fisher RG, Moodie DS, Sterba R, et al. Patent ductus arteriosus in adults--long-term follow-up: nonsurgical versus surgical treatment. J Am Coll Cardiol. 1986 Aug;8(2):280-4.

• 摘要

76.  Hong TE, Hellenbrand WE, Hijazi ZM, et al. Transcatheter closure of patent ductus arteriosus in adults using the Amplatzer duct occluder: initial results and follow-up. Indian Heart J. 2002 Jul-Aug;54(4):384-9.

• 摘要

77.  Pas D, Missault L, Hollanders G, et al. Persistent ductus arteriosus in the adult: clinical features and experience with percutaneous closure. Acta Cardiol. 2002 Aug;57(4):275-8.

• 摘要

78.  Yilmaz AT, Yorulmaz FM, Ozturk OY, et al. Ligation in adult persistent ductus arteriosus. J Cardiovasc Surg (Torino). 1991 Sep-Oct;32(5):575-80.

• 摘要

79.  Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews. 2011;(7):CD004213.

• 全文
• 摘要

80.  Ohlsson A, Bottu J, Govan J, et al. Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. Dev Pharmacol Ther. 1993;20(1-2):100-6.

• 摘要

81.  Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA. 1996 Feb 21;275(7):539-44.

• 摘要

82.  Heyman E, Morag I, Batash D, et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003 Nov;112(5):e354.

• 全文
• 摘要

83.  Gouyon JB, Kibleur Y. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants. Clin Ther. 2010 Sep;32(10):1740-8.

• 摘要

84.  Demir T, Oztunc F, Cetin G, et al. Patency or recanalization of the arterial duct after surgical double ligation and transfixion. Cardiol Young. 2007 Feb;17(1):48-50.

• 摘要

85.  Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. J Am Dent Assoc. 2007 Jun;138(6):739-45, 747-60.

• 摘要

86.  Brooks JM, Travadi JN, Patole SK, et al. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed. 2005;90:F235-F239.

• 全文
• 摘要

87.  Kabra NS, Schmidt B, Roberts RS, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007 Mar;150(3):229-34, 234.e1.

• 摘要

88.  Thilen U, Astrom-Olsson K. Does the risk of infective endarteritis justify routine patent ductus arteriosus closure? Eur Heart J. 1997;18:503-506.

• 全文
• 摘要

89.  Balzer DT, Spray TL, McMullin D, et al. Endarteritis associated with a clinically silent patent ductus arteriosus. Am Heart J. 1993;125:1192-1193.

• 摘要

90.  Parthenakis FI, Kanakaraki MK, Vardas PE. Images in cardiology: silent patent ductus arteriosus endarteritis. Heart. 2000;84:619.

• 全文
• 摘要

91.  Chen WJ, Chen JJ, Lin SC, et al. Detection of cardiovascular shunts by transesophageal echocardiography in patients with pulmonary hypertension of unexplained cause. Chest. 1995 Jan;107(1):8-13.

• 摘要

92.  Yan C, Zhao S, Jiang S, et al. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart. 2007 Apr;93(4):514-8.

• 摘要

93.  Dyamenahalli U, Smallhorn JF, Geva T, et al. Isolated ductus arteriosus aneurysm in the fetus and infant: a multi-institutional experience. J Am Coll Cardiol. 2000 Jul;36(1):262-9.

• 摘要

94.  Jan SL, Hwang B, Fu YC, et al. Isolated neonatal ductus arteriosus aneurysm. J Am Coll Cardiol. 2002 Jan 16;39(2):342-7.

• 摘要

95.  Mitchell RS, Seifert FC, Miller DC, et al. Aneurysm of the diverticulum of the ductus arteriosus in the adult. Successful surgical treatment in five patients and review of the literature. J Thorac Cardiovasc Surg. 1983 Sep;86(3):400-8.

• 摘要

96.  McFaul RC, Keane JF, Nowicki ER, et al. Aortic thrombosis in the neonate. J Thorac Cardiovasc Surg. 1981 Mar;81(3):334-7.

• 摘要

97.  National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. September 2015. http://www.nice.org.uk (last accessed 1 June 2016).

• 全文

98.  Graham TP Jr, Beekman RH 3rd, Allen HD, et al. ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation. 2005;112:2555-2580.

• 摘要